September 18th, 2019
For the relaunch of ISOPRINOSINE®, a leader product in the Eastern European markets (CEE), anken marketing communication ltd. was engaged by Ewopharma ltd. to design and implement the brand strategy and the lead campaign.
ISOPRINOSINE® (Rx only) with its unique dual action, antiviral and immunomodulatory, is approved for the treatment of acute respiratory diseases (e.g., acute bronchitis) and HPV infections.
The unique dual effect (USP) is represented by the Victory sign of the respective user group. The two colors orange and yellow (only for HCP's) form the reference to the newly revised package, which is an unmistakable trademark of the campaign and the recognition effect even stronger.
June 14th, 2018
Since June 1st, 2018, we support the communications department at Swiss Olympic as an interim manager and immerse ourselves in the world of sports!
April 10th, 2018
amc is pleased to support ViiV Healthcare in medical marketing communication. ViiV Healthcare is focused on researching new medicines to improve outcomes for people living with HIV and understanding how best to prevent and treat the disease.
September 19th, 2017
amc will support GSK in the indication of respiratory. GSK has been one of the leading companies in this sector for years, which is also reflected in a broad pipeline. We're looking forward to work with GSK!
August 10th, 2017
amc supports the pharmaceutical company Ewopharma Ltd. in BD & L projects. We analyze, elaborate decision-making and provide comprehensive advice.
June 12th, 2017
amc wins the pitch of Servier Oncology and supports the company in launching an innovative product.